Acute Myeloid Leukemia Clinical Trial

Clinical Trial Finder Acute Myeloid Leukemia Trials

An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia

See Locations Near You

Summary

The purpose of this study is to determine the safety and effectiveness of ulocuplumab in combination with low dose cytarabine in the treatment of Newly Diagnosed Acute Myeloid Leukemia (AML).

View Eligibility Criteria

Eligibility Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

Newly Diagnosed Acute Myeloid Leukemia (AML)
Considered inappropriate for intensive remission induction therapy by an investigator
Not eligible for stem cell transplantation

Exclusion Criteria:

Acute promyelocytic leukemia
Current Myelodysplastic syndrome only subjects
Unstable angina or uncontrolled congestive heart failure
Any other malignancy, excluding basal or squamous cell carcinoma of the skin, in situ melanoma, cervical carcinoma in situ, localized prostate cancer, or superficial bladder cancer stage 0, from which the subject has not been disease-free for at least 3 years
Respiratory disease requiring continuous supplemental oxygen

Other protocol defined inclusion/exclusion criteria could apply

Study is for people with:

Acute Myeloid Leukemia

Phase:

Phase 1

Estimated Enrollment:

70

Study ID:

NCT02305563

Recruitment Status:

Terminated

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 37 Locations for this study

See Locations Near You

Ucla Center Health Sci
Los Angeles California, 90095, United States
UF Health Cancer Center at Orlando Health
Orlando Florida, 32806, United States
Norton Cancer Institute
Louisville Kentucky, 40207, United States
NYU Langone Medical Center
New York New York, 10016, United States
Duke University Adult Bone Marrow Transplant Clinic
Durham North Carolina, 27705, United States
University Of Cincinnati
Cincinnati Ohio, 45219, United States
Cleveland Clinic Taussig Cancer Center
Cleveland Ohio, 44195, United States
The University Of Texas MD Anderson Cancer Center
Houston Texas, 77030, United States
Froedtert Hospital & Medical College of Wisconsin
Milwaukee Wisconsin, 53226, United States
Liga Paranaense De Combate Ao Cancer Erasto Gaertner
Curitiba Parana, 81520, Brazil
Instituto Do Cancer Mae De Deus / Cor Hospital Mae De Deus
Porto Alegre RIO Grande DO SUL, 90110, Brazil
Fundacao Pio Xii Hosp Cancer De Barretos
Barretos Sao Paulo, 14784, Brazil
IEP Sao Lucas
Sao Paulo , 01236, Brazil
Local Institution
Sao Paulo , 01246, Brazil
Local Institution
Sao Paulo , 05651, Brazil
Local Institution
Halifax Nova Scotia, B3H 2, Canada
Local Institution
Hong Kong , , China
Local Institution
Jerusalem , 91031, Israel
Local Institution
Tel Aviv , 94239, Israel
Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele
Catania , 95123, Italy
Local Institution
Milan , 20162, Italy
Azienda Ospedaliera Di Rilievo Nazionale A. Cardarelli
Napoli , 80131, Italy
Local Institution
Roma , 00133, Italy
Local Institution
Nagoya-shi Aichi, 46000, Japan
Local Institution
Fukuyama-shi Hiroshima, 72000, Japan
Local Institution
Isehara Kanagawa, 25911, Japan
Local Institution
Hirakata-shi Osaka, 57311, Japan
Local Institution
Bunkyo-ku Tokyo, 11386, Japan
Local Institution
Shinagawa-ku Tokyo, 14186, Japan
Local Institution
Shinjuku-Ku Tokyo, 16085, Japan
Local Institution
Tachikawa Tokyo, 19000, Japan
Local Institution
Seoul , 06351, Korea, Republic of
Local Institution
Seoul , 06591, Korea, Republic of
Local Institution
Bucharest , 02012, Romania
Local Institution
Kaohsiung , 833, Taiwan
Local Institution
New Taipei City , 235, Taiwan
Local Institution
New Taipei City , 25173, Taiwan
Local Institution
Taoyuan City , 33305, Taiwan
Load More

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Phase:

Phase 1

Estimated Enrollment:

70

Study ID:

NCT02305563

Recruitment Status:

Terminated

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider